Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Pediatric Gastroenterology

Nutrition, Monitoring, and Life Long-Term

At a Glance

Long-term care for children with ALPI-related IBD protects growth through dietitian-guided nutrition, regular blood and stool inflammation checks, follow-up after surgery, and support for caregiver and family well-being.

Managing ALPI-related IBD is a marathon, not a sprint. Because this condition is driven by a genetic alteration, the focus of long-term care shifts from just stopping a flare to actively protecting your child’s growth and development. This requires a proactive, “eyes-wide-open” approach to nutrition and monitoring.

Prioritizing Growth and Nutrition

In children with monogenic IBD, nutrition is not just about calories—it is a medical intervention. Severe inflammation can “steal” energy that should be used for growing, leading to failure to thrive [1][2].

Your care team should include a specialized pediatric dietitian to help manage:

  • Nutritional Optimization: This may involve Exclusive Enteral Nutrition (EEN)—a specialized liquid formula diet extrapolated from pediatric Crohn’s evidence to induce mucosal healing and support growth [3][4]. EEN involves drinking 100% of daily calories from formula, which is challenging, not feasible for all, and requires strict dietitian supervision.
  • Micronutrient Monitoring: Inflammation and surgery can prevent the body from absorbing vital nutrients. Your child needs regular screening for:
    • Iron: Anemia is common and should be managed by testing ferritin and iron stores, not just hemoglobin [5][6].
    • Vitamin D and Calcium: Essential for bone health, which can be weakened by both IBD and steroid use [7][8].
    • Vitamin B12: Particularly important if the terminal ileum (the end of the small intestine) has been affected or surgically removed [7].
  • Parenteral Nutrition (PN): In severe cases where the gut cannot absorb enough nutrients, nutrients may be delivered directly into the bloodstream through a central line [9][10]. PN carries risks of central-line infections, blood clots, and liver complications, and is used only when benefits outweigh the risks.

Practically, manage hydration with specific oral rehydration solutions (ORS) instead of plain water or sugary sports drinks, which can worsen diarrhea or high stoma output.

The Surveillance Schedule: Beyond Symptoms

In ALPI-related IBD, symptoms (like pain or diarrhea) do not always tell the whole story. A child can feel “fine” while significant inflammation is still damaging the gut lining [11]. To stay ahead of the disease, doctors often use a treat-to-target approach [12].

Standard Monitoring Targets:

  1. Blood Markers: Regular checks of C-reactive protein (CRP) and ESR to look for systemic inflammation [13]. Note that these can be normal despite active disease.
  2. Stool Markers: Fecal calprotectin is a powerful tool that measures inflammation directly in the gut [11][13]. However, it can be affected by infections, and there is no universal ALPI-specific threshold. Never change treatment on a single marker without clinical interpretation.
  3. Endoscopic Surveillance: Periodic colonoscopies or endoscopies are used to confirm “mucosal healing”—meaning the gut lining actually looks healthy under a microscope, which is an important objective target [12][14]. Frequency is individualized to balance the need for information against anesthesia risks.

Life After Surgery

If your child requires surgery, such as a resection or colectomy, their daily management will change.

  • Post-Resection Monitoring: After surgery, the team will use fecal calprotectin and imaging (like intestinal ultrasound) to watch for any signs of the disease returning at the site where the intestine was reconnected [15][16].
  • Pouch Management: If a “pouch” was created, your child will need monitoring for pouchitis (inflammation of the pouch) or other complications that can mimic a return of IBD [17][18]. A pouch may be inappropriate if Crohn’s-like disease is possible, making surgical planning an individualized decision.

The Psychological Toll on the Family

Caring for a child with an ultra-rare, refractory condition is an extraordinary emotional and physical weight. Research shows that caregivers of children with complex, chronic illnesses often experience higher levels of caregiver burden, anxiety, and depression [19][20].

  • The “Pioneer” Stress: Being the parent of a child with a disease that has few precedents can lead to a sense of isolation.
  • Resilience and Hope: Studies suggest that building a strong support network—including social workers, peer support groups, and mental health professionals—can help improve the whole family’s quality of life [21][22].
  • Siblings: Don’t forget that siblings also feel the impact of the “indirect costs” of care, including lost time and the emotional stress of a sick brother or sister [23].

Your specialized center is there to care for the whole family, not just the patient. Do not hesitate to ask for psychosocial resources, such as helping coordinate a 504 plan (or equivalent school accommodation plan), as part of your child’s standard care plan [24][25].

Common questions in this guide

How can nutrition support growth in a child with ALPI-related IBD?
Inflammation can use energy needed for growth and can interfere with nutrient absorption. A pediatric dietitian may recommend individualized nutrition support, including Exclusive Enteral Nutrition (EEN) in some cases. EEN may support gut healing and growth, but it is difficult and not suitable for every child.
Which vitamins and minerals should be checked in ALPI-related IBD?
Care teams commonly monitor iron stores with ferritin, along with vitamin D and calcium for bone health. Vitamin B12 is especially important when the terminal ileum has been affected or removed, and the testing schedule should be individualized.
Can my child have active ALPI-related IBD even if they feel well?
Yes. A child may have significant gut inflammation without much pain or diarrhea, and CRP or ESR can sometimes be normal. Fecal calprotectin, imaging, and periodic endoscopy may provide additional information, but one result should not change treatment without clinical interpretation.
What does a high fecal calprotectin result mean for a child with ALPI-related IBD?
A high result can signal inflammation in the intestine, but infections and other factors can also raise it, and there is no universal ALPI-specific cutoff. The care team should interpret the result with symptoms, blood tests, and other findings before changing treatment.
How is my child monitored after bowel surgery for ALPI-related IBD?
After a resection or colectomy, clinicians may use fecal calprotectin and imaging such as intestinal ultrasound to look for inflammation returning near a reconnection. If a pouch was created, monitoring also checks for pouchitis and other complications that can resemble recurrent IBD.
When is parenteral nutrition used in ALPI-related IBD?
Parenteral nutrition may be used when the intestine cannot absorb enough nutrients and nutrition must be delivered through a central line. Because it can cause central-line infection, blood clots, and liver complications, clinicians use it only when the benefits outweigh the risks.
What support is available for families caring for a child with ultra-rare ALPI-related IBD?
Care teams may connect families with social workers, peer support, mental health professionals, and school accommodation planning such as a 504 plan. These supports can help with caregiver stress, sibling impact, and day-to-day coordination.

Get notified when new evidence is published on ALPI-related inflammatory bowel disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (25)
  1. 1

    Nutritional Approach in Pediatric Patients with Inflammatory Bowel Disease: Treatment, Risk and Challenges.

    Capra ME, Bellani AM, Berzieri M, et al.

    Nutrients 2025; (17(22)) doi:10.3390/nu17223545.

    PMID: 41305596
  2. 2

    Role of ileal diversion in pediatric inflammatory bowel disease.

    Simard AA, Kotamraju S, DeFazio JR, Picoraro JA

    Journal of pediatric gastroenterology and nutrition 2024; (79(4)):800-806 doi:10.1002/jpn3.12331.

    PMID: 39075806
  3. 3

    Exclusive enteral nutrition for inducing remission in inflammatory bowel disease in paediatric patients.

    Assa A, Shamir R

    Current opinion in clinical nutrition and metabolic care 2017; (20(5)):384-389 doi:10.1097/MCO.0000000000000402.

    PMID: 28768295
  4. 4

    Diet and Nutrition in Pediatric Inflammatory Bowel Diseases.

    Cucinotta U, Romano C, Dipasquale V

    Nutrients 2021; (13(2)) doi:10.3390/nu13020655.

    PMID: 33671453
  5. 5

    Anemia in Children With Inflammatory Bowel Disease: A Position Paper by the IBD Committee of the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition.

    Goyal A, Zheng Y, Albenberg LG, et al.

    Journal of pediatric gastroenterology and nutrition 2020; (71(4)):563-582 doi:10.1097/MPG.0000000000002885.

    PMID: 32947565
  6. 6

    Iron Deficiency Anemia in Inflammatory Bowel Diseases-A Narrative Review.

    Mahadea D, Adamczewska E, Ratajczak AE, et al.

    Nutrients 2021; (13(11)) doi:10.3390/nu13114008.

    PMID: 34836263
  7. 7

    Daily Vitamin D3 Versus Stoss Vitamin D3 for Correction of 25OHD Deficiency in Children with Inflammatory Bowel Disease, a Randomised Controlled Trial.

    O'Donnell JEM, Leach ST, Bowcock NL, et al.

    Digestive diseases and sciences 2025; (70(5)):1844-1853 doi:10.1007/s10620-025-08913-3.

    PMID: 40021606
  8. 8

    RANKL/OPG Axis and Bone Mineral Density in Pediatric Inflammatory Bowel Disease.

    Olczyk M, Frankowska A, Tkaczyk M, et al.

    Journal of clinical medicine 2025; (14(15)) doi:10.3390/jcm14155440.

    PMID: 40807060
  9. 9

    Failure to thrive: A severe manifestation of interleukin 10 receptor A mutation in adult inflammatory bowel disease.

    Ruiz NC, Kamel AY, Liu X, et al.

    JPEN. Journal of parenteral and enteral nutrition 2022; (46(1)):238-242 doi:10.1002/jpen.2254.

    PMID: 34423458
  10. 10

    Clinical Phenotypes and Outcomes in Monogenic Versus Non-monogenic Very Early Onset Inflammatory Bowel Disease.

    Collen LV, Kim DY, Field M, et al.

    Journal of Crohn's & colitis 2022; (16(9)):1380-1396 doi:10.1093/ecco-jcc/jjac045.

    PMID: 35366317
  11. 11

    Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.

    Hoekman DR, Diederen K, Koot BG, et al.

    European journal of pediatrics 2016; (175(10)):1335-42 doi:10.1007/s00431-016-2762-2.

    PMID: 27573259
  12. 12

    STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.

    Turner D, Ricciuto A, Lewis A, et al.

    Gastroenterology 2021; (160(5)):1570-1583 doi:10.1053/j.gastro.2020.12.031.

    PMID: 33359090
  13. 13

    Assessing the correlation between fecal calprotectin, blood markers and disease activity in pediatric inflammatory bowel disease.

    Plume JL, De A, Mutalib M

    Annals of gastroenterology 2024; (37(4)):436-441 doi:10.20524/aog.2024.0892.

    PMID: 38974077
  14. 14

    Real-world data on STRIDE-II treatment targets in a pediatric cohort with inflammatory bowel disease.

    Frank ML, Thi TGL, Schacker I, et al.

    Journal of pediatric gastroenterology and nutrition 2026; (82(4)):1006-1018 doi:10.1002/jpn3.70345.

    PMID: 41549471
  15. 15

    Fecal calprotectin in the prediction of postoperative recurrence of Crohn's disease in children and adolescents.

    Hukkinen M, Pakarinen MP, Merras-Salmio L, et al.

    Journal of pediatric surgery 2016; (51(9)):1467-72.

    PMID: 26891835
  16. 16

    Intestinal Ultrasound for the Pediatric Gastroenterologist: A Guide for Inflammatory Bowel Disease Monitoring in Children: Expert Consensus on Behalf of the International Bowel Ultrasound Group (IBUS) Pediatric Committee.

    Kellar A, Dolinger M, Novak KL, et al.

    Journal of pediatric gastroenterology and nutrition 2023; (76(2)):142-148 doi:10.1097/MPG.0000000000003649.

    PMID: 36306530
  17. 17

    Endoscopy in Postoperative Patients with Crohn's Disease or Ulcerative Colitis. Does It Translate to Better Outcomes?

    Bhattacharya A, Shen B, Regueiro M

    Gastrointestinal endoscopy clinics of North America 2019; (29(3)):487-514 doi:10.1016/j.giec.2019.02.013.

    PMID: 31078249
  18. 18

    Outcomes Following Pouch Formation in Paediatric Ulcerative Colitis: A Study From the Porto Group of ESPGHAN.

    Orlanski-Meyer E, Topf-Olivestone C, Ledder O, et al.

    Journal of pediatric gastroenterology and nutrition 2020; (71(3)):346-353 doi:10.1097/MPG.0000000000002805.

    PMID: 32541197
  19. 19

    Proxy-reported quality of life of children with intestinal pseudo-obstruction and caregivers' self-reported health outcomes in China.

    Cai C, Wang Y, You Y, et al.

    Journal of pediatric gastroenterology and nutrition 2026; doi:10.1002/jpn3.70586.

    PMID: 42775515
  20. 20

    Systematic review of indirect costs to families of children with developmental epileptic encephalopathies.

    Abdelmageed S, Du RY, Carroll M, et al.

    Orphanet journal of rare diseases 2025; (20(1)):579 doi:10.1186/s13023-025-04081-9.

    PMID: 41225515
  21. 21

    The mediating role of resilience between caregiver burden and hope among patients with inflammatory bowel disease.

    Zhou M, Wang M, Luo D, et al.

    Nursing open 2024; (11(8)):e70001 doi:10.1002/nop2.70001.

    PMID: 39189092
  22. 22

    Effectiveness of family centred interventions for family caregivers: A systematic review and meta-analysis of randomized controlled trials.

    Wang Z, Yu S, Liu Y, et al.

    Journal of clinical nursing 2024; (33(5)):1958-1975 doi:10.1111/jocn.17091.

    PMID: 38439168
  23. 23

    Impact of developmental and epileptic encephalopathies on caregivers: A literature review.

    Gallop K, Lloyd AJ, Olt J, Marshall J

    Epilepsy & behavior : E&B 2021; (124()):108324 doi:10.1016/j.yebeh.2021.108324.

    PMID: 34607217
  24. 24

    Caregiver burden among parents of children with type 1 diabetes: A qualitative scoping review.

    Azimi T, Johnson J, Campbell SM, Montesanti S

    Heliyon 2024; (10(6)):e27539 doi:10.1016/j.heliyon.2024.e27539.

    PMID: 38524615
  25. 25

    Issues navigating the healthcare delivery system among caregivers of children and youth with special healthcare needs: a qualitative study.

    Meyer CM, Campbell RK, Kelleher MR, et al.

    BMC health services research 2026; (26(1)).

    PMID: 42277773

This page is for informational purposes only and does not constitute medical advice about your child’s ALPI-related IBD. Your child’s IBD team should guide nutrition, monitoring, supplements, hydration, and treatment decisions.

Guide contents ALPI-related inflammatory bowel disease
Research & Literature
05 Treatment Strategies and the Role of Surgery